HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhenzhou Shen Selected Research

trioctyl phosphine oxide (TOPO)

10/2011The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhenzhou Shen Research Topics

Disease

24Breast Neoplasms (Breast Cancer)
04/2018 - 06/2007
13Neoplasms (Cancer)
01/2018 - 05/2002
2Amenorrhea
04/2018 - 10/2015
2Hypoxia (Hypoxemia)
01/2018 - 04/2015
2Neoplasm Metastasis (Metastasis)
01/2011 - 02/2008
1Residual Neoplasm
01/2017
1Thrombosis (Thrombus)
03/2016
1Postoperative Pain
03/2016
1Postmenopausal Osteoporosis
04/2015
1Diabetes Mellitus
04/2015
1Fat Necrosis
04/2014
1Diarrhea
06/2013
1Neutropenia
06/2013
1Disease Progression
12/2010
1Neoplasm Micrometastasis
05/2002

Drug/Important Bio-Agent (IBA)

8Estrogen ReceptorsIBA
04/2018 - 06/2007
4Progesterone Receptors (Progesterone Receptor)IBA
02/2011 - 06/2007
3Estrogens (Estrogen)FDA Link
01/2018 - 06/2007
3Hormones (Hormone)IBA
01/2017 - 04/2009
3ErbB Receptors (EGF Receptor)IBA
07/2014 - 08/2010
3Paclitaxel (Taxol)FDA LinkGeneric
07/2014 - 12/2010
3AnthracyclinesIBA
01/2012 - 12/2010
2Zoledronic Acid (Zometa)FDA Link
01/2018 - 04/2015
2Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2007
2Aromatase InhibitorsIBA
01/2017 - 02/2011
2Letrozole (Femara)FDA LinkGeneric
01/2017 - 04/2015
2Lapatinib (GW572016)FDA Link
07/2014 - 06/2013
2taxaneIBA
01/2012 - 10/2011
2Trastuzumab (Herceptin)FDA Link
03/2011 - 01/2011
2human ERBB2 proteinIBA
03/2011 - 10/2009
1Estradiol (Delestrogen)FDA LinkGeneric
04/2018
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
04/2018
1Follicle Stimulating Hormone (Follitropin)FDA Link
04/2018
1fluoromisonidazoleIBA
01/2018
1Fulvestrant (Faslodex)FDA Link
01/2018
1Cysteine (L-Cysteine)FDA Link
01/2017
1N(4)-chloroacetylcytosine arabinoside (CACA)IBA
10/2015
1Pharmaceutical PreparationsIBA
04/2015
1Epidermal Growth Factor (EGF)IBA
04/2015
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2014
1TensinsIBA
07/2014
1Histone Deacetylases (Histone Deacetylase)IBA
01/2014
1Proteasome InhibitorsIBA
01/2014
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
01/2014
1Histone Deacetylase InhibitorsIBA
01/2014
1Bortezomib (Velcade)FDA Link
01/2014
1suberoyl bis-hydroxamic acidIBA
01/2014
1Capecitabine (Xeloda)FDA Link
01/2012
1trioctyl phosphine oxide (TOPO)IBA
10/2011
1Trefoil FactorsIBA
02/2011
1TamoxifenFDA LinkGeneric
02/2011
1GemcitabineFDA Link
12/2010
1Aldehyde Dehydrogenase 1 FamilyIBA
08/2010
1SulfotransferasesIBA
07/2010
1ParaffinIBA
10/2009
1Vinorelbine (Navelbine)FDA LinkGeneric
10/2009
1Formaldehyde (Formol)FDA Link
10/2009
1Epirubicin (Ellence)FDA LinkGeneric
10/2009
1Docetaxel (Taxotere)FDA Link
04/2008
1Mitoxantrone (Novantrone)FDA LinkGeneric
04/2008
1Aromatase (CYP19)IBA
06/2007
1AndrogensIBA
06/2007
1Coloring Agents (Dyes)IBA
05/2002
1AntibodiesIBA
05/2002

Therapy/Procedure

7Drug Therapy (Chemotherapy)
04/2018 - 12/2010
6Adjuvant Chemotherapy
04/2018 - 01/2011
6Therapeutics
01/2017 - 12/2010
3Neoadjuvant Therapy
10/2011 - 10/2009
2Mammaplasty (Breast Reconstruction)
11/2014 - 04/2014
1Aftercare (After-Treatment)
01/2017
1Epidural Anesthesia
03/2016
1General Anesthesia
03/2016
1Castration
10/2015
1Radiotherapy
04/2015
1Mastectomy (Mammectomy)
11/2014
1Free Tissue Flaps
04/2014
1Salvage Therapy
01/2012
1Combination Drug Therapy (Combination Chemotherapy)
10/2011
1Extended Radical Mastectomy
02/2008